A Russian-made drug, Favipiravir that may help treat COVID-19 is a step closer to being released after moving into the final stages of clinical trials.
The drug has several advantages including significantly reducing patient recovery time, and its availability in tablet form, making it easier to use, according to an earlier statement from the RDIF. “Thanks to the administration of Favipiravir, most patients are not infectious as early as the fifth day of treatment, which is critical to stop the epidemic and ensure a swift return to normal life,” Yakubova added.
Hope rising and lockdown is about locked out in Nigeria a major subsistent economy.
Good effort
That is if WHO will not out of corruption and politics reject the drug.
I think the Russian tech community is diversifying from their usual base which is weaponry.
Good one
Good news 👏
We're getting there, I pray it's finally approved by WHO, the WORLD will go back to normal.
Land of the wise..
Nobody is talking about Madagascar herb
Nigeria Latest News, Nigeria Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: MobilePunch - 🏆 8. / 63 Read more »
Source: PremiumTimesng - 🏆 3. / 78 Read more »
Dashed Hopes: How Nigerian Research Agencies Spent N500m On Clinical Trials Of Local Drugs With No Commercial Output | Sahara ReportersThe Civic Media Lab found that Nigerian government budgeted for a total of eight human-related clinical trials of locally produced drugs between 2015 and 2019 with no evidence of commercial output. What a nation 😫😫😫 😂 yet nothing come out
Source: SaharaReporters - 🏆 9. / 63 Read more »
Source: Daily Trust - 🏆 13. / 51 Read more »
Source: TheNationNews - 🏆 6. / 69 Read more »
Source: channelstv - 🏆 7. / 63 Read more »